USPTO serial 97157132
CONFOCHIMERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 13, 2023
- Examiner
- KON, ELISSA GARBER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CONFOCHIMERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zwijnaarde, BE
Zwijnaarde, BE
Zwijnaarde, BE
GENT, BE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth A. Cominolli
Elizabeth A. Cominolli MARKERT & COMINOLLI PLLC75 S. CLINTON AVE., SUITE 510ROCHESTER, NY 14604UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely, antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); Chemical substances for use in the production of drugs; Biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; Chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs) | ACTIVE | — |
| 042 | Medical and pharmacological research services; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Research and development of vaccines and medicines; Scientific research for medical purposes and the development of pharmaceutical preparations in the area of chimeric proteins, antibodies for stabilization of proteins and G protein-coupled receptors (GPCRs) | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Confo Therapeutics N.V.
- Other trademarks owned by Confo Therapeutics N.V.
- Other trademarks owned by Confo Therapeutics N.V.
- Other trademarks owned by CONFO THERAPEUTICS NV
- Other trademarks in Class 001
- Other trademarks in Class 042
- Similar marks named CONFOCHIMERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 13, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 13, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 21, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 16, 2023 | ALIE | ASSIGNED TO LIE | — |
| Dec 14, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 14, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 14, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 14, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 14, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 10, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 9, 2021 | NWAP | NEW APPLICATION ENTERED | — |